Routine utilization of glycoprotein IIb/IIIa inhibitor therapy is associated with improved in-hospital outcome after percutaneous coronary intervention: insights from a large prospective single-centre registry
Jackevicius CA, Pinto R, Daly P, Mackie K, Dzavik V. Can J Cardiol. 2005; 21(1):27-32.